Estimaciones de analistas de Wall Street para Atossa Therapeutics, Inc. (ATOS): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.92 | ||
| 2026-08-07 | $-0.95 | $-1.02 | +6.9% |
| 2026-05-08 | $-1.11 | $-1.22 | +9.0% |
| 2026-03-25 | $-1.19 | $-1.14 | -4.6% |
| 2025-11-12 | $-1.05 | $-0.97 | -7.7% |
| 2025-08-12 | $-1.05 | $-0.90 | -16.7% |
| 2025-05-13 | $-0.75 | $-0.06 | -1150.0% |
| 2025-03-25 | $-0.75 | $-0.90 | +16.7% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $303482 | $128994 | $44197 | $52789 | $46600 | $23000 | $8000 | $23000 | $17000 | 0 |
| Beneficio Bruto | -$303482 | -$128994 | -$44197 | -$52789 | -$46600 | -$23000 | -$8000 | -$23000 | -$17000 | 0 |
| I+D | $770427 | $2.3M | $4.2M | $7.1M | $6.6M | $9.2M | $15.1M | $17.3M | $14.1M | $21.2M |
| Generales y Administrativos | $6.5M | $4.9M | $7.2M | $10.6M | $8.0M | $11.3M | $12.6M | $14.0M | $13.5M | $16.0M |
| Gastos Operativos | $6.9M | $7.1M | $11.4M | $17.3M | $14.6M | $20.5M | $27.7M | $31.4M | $27.6M | $37.1M |
| Beneficio Operativo | -$7.2M | -$7.2M | -$11.4M | -$17.3M | -$14.6M | -$20.5M | -$27.7M | -$31.4M | -$27.6M | -$37.1M |
| EBITDA | -$6.1M | -$7.8M | -$11.4M | -$17.2M | -$14.6M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| Gastos por Intereses | 0 | $192817 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$6.4M | -$8.1M | -$11.4M | -$17.2M | -$17.8M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| Impuestos | 0 | 0 | -$29299 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$6.4M | -$8.1M | -$11.4M | -$17.2M | -$17.8M | -$20.6M | -$27.0M | -$30.1M | -$25.5M | -$34.8M |
| BPA | $-388.95 | $-164.55 | $-82.50 | $-30.45 | $-29.55 | $-2.70 | $-3.15 | $-3.60 | $-3.00 | $-4.04 |
| BPA Diluido | $-388.95 | $-164.55 | $-82.50 | $-30.45 | $-29.55 | $-2.70 | $-3.15 | $-3.60 | $-3.00 | $-4.04 |
| Acciones en Circulación (Diluidas) | $16374 | $64985 | $277183 | $566464 | $753902 | $7.8M | $8.4M | $8.4M | $8.4M | $8.6M |
Precio
| Precio | $2.42 |
| Capitalización | $24M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: CGTX · CLNN · COYA · GLSI · IMMX · ONCY · SRZN
Explorar sector: Healthcare · Biotechnology
Más secciones de ATOS: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones